Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q2 2024 · 10-Q
Revenue$286.32M$286.32M−1.0% vs Q2 2023 Net Income$53.56M$53.56M+5.0% vs Q2 2023 EPS Diluted$1.07$1.07+4.9% vs Q2 2023 Gross Profit$160,020,000−0.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$62,460,000+8.6% Free Cash Flowderived$59,526,000+7.9% Margins · derivedGross margin55.9%+0.2 pt vs Q2 2023
Operating margin30.8%+1.7 pt vs Q2 2023
Net margin18.7%+1.1 pt vs Q2 2023
ended Sep 30, 2023 · filed Nov 2, 2023 · 33 d after period end